In the fast-paced world of MedTech, where innovation meets stringent regulations, turning website visitors into qualified leads can be a daunting challenge. That's where TheSkinnyAI comes in. Founded in 2025 by industry veteran Andrew Dallas, TheSkinnyAI is an intelligent AI assistant designed specifically for B2B environments, particularly in medical device manufacturing and contract services. Our mission is simple yet transformative: to empower sales teams by converting passive website browsers into engaged, high-value prospects—24/7, without the need for constant human intervention.
Drawing from decades of experience in medical device development, TheSkinnyAI bridges the gap between complex technical expertise and buyer needs. It engages visitors instantly, answers intricate queries on topics like regulatory compliance, biocompatibility testing, or sustainable supply chains, and qualifies leads by uncovering pain points such as product launch delays or cost inefficiencies. The result? Shorter sales cycles, higher conversion rates, and a streamlined path to growth in an industry where trust and precision are paramount.
Andrew Dallas is a pioneering force in medical device software, with over 30 years of expertise in product development, project management, and regulatory compliance. As the founder and former president of Full Spectrum Software, Inc.—a leading firm specializing in compliant, innovative medical devices, life sciences equipment, and digital health solutions—Andrew has been instrumental in bringing life-changing technologies to market since 1997.
His journey in MedTech has seen him guide multidisciplinary teams through the intricacies of FDA regulations (including 21 CFR Part 820 and ISO 13485), cybersecurity, AI integration, and agile methodologies. Recognizing the slower pace of AI adoption in MedTech—despite its potential to revolutionize operations—Andrew spearheaded TheSkinnyAI as an extension of his work driving AI across engineering, testing, verification, and sales pipelines.
Today, as AI Strategy Lead, Andrew continues to champion tools that deliver quick ROI, such as boosting B2B sales conversions by 20–30% and reducing deal cycles by up to 30%. His vision for TheSkinnyAI is rooted in real-world challenges: empowering sales teams to focus on relationships while AI handles the heavy lifting of education and qualification. Andrew's advisory roles, including on the board of Muraena, further underscore his commitment to advancing AI in regulated industries.
At its core, TheSkinnyAI is built for MedTech contract manufacturers and service providers who need a "sales engine" that never sleeps. Unlike generic chatbots, our AI is tailored to the nuances of B2B MedTech sales—educating buyers on specialized capabilities, like cutting costs through sustainable sourcing by 15–25%, and handing off warm leads to human reps for seamless closure.
We're not just another tool; we're a partner in accelerating your AI revolution. In a sector where 95% of enterprises prioritize AI for customer engagement, TheSkinnyAI positions you at the forefront, turning your website into a powerhouse of opportunity.
Join us in redefining MedTech sales. Discover how TheSkinnyAI can transform your leads today.